Copyright
©The Author(s) 2016.
World J Hepatol. Jun 18, 2016; 8(17): 703-715
Published online Jun 18, 2016. doi: 10.4254/wjh.v8.i17.703
Published online Jun 18, 2016. doi: 10.4254/wjh.v8.i17.703
Figure 7 Prognostic scores designed to transarterial chemoembolization, an aid to the decision making process: In practice.
BCLC: Barcelona Clinic Liver Cancer; HCC: Hepatocellular carcinoma; TACE: Transarterial chemoembolization; CT: Computed tomography; ART: Assessment for Retreatment with TACE; ECOG (PS), Eastern Cooperative Oncology Group (Performance Status); RFA: Radiofrequency ablation; HAP: Hepatoma Arterial-embolisation Prognostic; MRI: Magnetic resonance imaging.
- Citation: Adhoute X, Penaranda G, Raoul JL, Le Treut P, Bollon E, Hardwigsen J, Castellani P, Perrier H, Bourlière M. Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments. World J Hepatol 2016; 8(17): 703-715
- URL: https://www.wjgnet.com/1948-5182/full/v8/i17/703.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i17.703